Investigating further the inflammatory pathways that dictate respiratory depression, particularly those involved in driving the production of the key inflammatory proteins (e.g., IL-1 and IL-6) associated with exposure to perinatal infection/inflammation and respiratory depression, may reveal future therapeutic targets. The gene discussed is IL6; the disease is Respiratory insufficiency due to muscle weakness.